Yang L - Search Results

1

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.

Liu P, Tang H, Chen B, He Z, Deng M, Wu M, Liu X, Yang L, Ye F, Xie X. Liu P, et al. Among authors: yang l. Cancer Lett. 2015 Feb 1;357(1):384-392. doi: 10.1016/j.canlet.2014.11.050. Epub 2014 Nov 27. Cancer Lett. 2015. PMID: 25434799

2

Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.

Lin X, Wu M, Liu P, Wei F, Li L, Tang H, Xie X, Liu X, Yang L, Xie X. Lin X, et al. Among authors: yang l. Med Oncol. 2014 Apr;31(4):868. doi: 10.1007/s12032-014-0868-9. Epub 2014 Feb 22. Med Oncol. 2014. PMID: 24563327

3

Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.

Xie X, Kong Y, Tang H, Yang L, Hsu JL, Hung MC. Xie X, et al. Among authors: yang l. Mol Cancer Ther. 2014 Jul;13(7):1813-25. doi: 10.1158/1535-7163.MCT-13-1004. Epub 2014 Apr 30. Mol Cancer Ther. 2014. PMID: 24785255 Free PMC article.

4

Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis.

Yang L, Li N, Wang S, Kong Y, Tang H, Xie X, Xie X. Yang L, et al. Asian Pac J Cancer Prev. 2014;15(12):4823-7. doi: 10.7314/apjcp.2014.15.12.4823. Asian Pac J Cancer Prev. 2014. PMID: 24998547 Free article.

5

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.

Chen B, Tang H, Liu X, Liu P, Yang L, Xie X, Ye F, Song C, Xie X, Wei W. Chen B, et al. Among authors: yang l. Cancer Lett. 2015 Jan 28;356(2 Pt B):410-7. doi: 10.1016/j.canlet.2014.09.028. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25304371

6

Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer.

Xie X, Tang H, Pengliu, Kong Y, Wu M, Xiao X, Yang L, Gao J, Wei W, Lee J, Bartholomeusz C, Ueno NT, Xie X. Xie X, et al. Among authors: yang l. Cancer Lett. 2015 Jan 28;356(2 Pt B):374-381. doi: 10.1016/j.canlet.2014.09.033. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25304382 Free PMC article.

7

miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.

Tang H, Liu P, Yang L, Xie X, Ye F, Wu M, Liu X, Chen B, Zhang L, Xie X. Tang H, et al. Among authors: yang l. Mol Cancer Ther. 2014 Dec;13(12):3185-97. doi: 10.1158/1535-7163.MCT-14-0243. Epub 2014 Oct 15. Mol Cancer Ther. 2014. PMID: 25319390

8

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.

Liu X, Tang H, Chen J, Song C, Yang L, Liu P, Wang N, Xie X, Lin X, Xie X. Liu X, et al. Among authors: yang l. Oncotarget. 2015 Aug 21;6(24):20070-83. doi: 10.18632/oncotarget.4039. Oncotarget. 2015. PMID: 26036638 Free PMC article.

9

LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.

Yang L, Tang H, Kong Y, Xie X, Chen J, Song C, Liu X, Ye F, Li N, Wang N, Xie X. Yang L, et al. Stem Cells. 2015 Oct;33(10):2913-24. doi: 10.1002/stem.2083. Epub 2015 Jul 14. Stem Cells. 2015. PMID: 26086949

10

miR-200c inhibits breast cancer proliferation by targeting KRAS.

Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye F, Xie X, Chen J, Tang H, Xie X. Song C, et al. Among authors: yang l. Oncotarget. 2015 Oct 27;6(33):34968-78. doi: 10.18632/oncotarget.5198. Oncotarget. 2015. PMID: 26392416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56,792 results

Search Page

Filters